PPARGC1A and Parkinson disease: This work reports the amelioration of mitochondrial dysfunction and alleviation of PD symptoms by promoting neuronal mitochondrial biogenesis via NAD+/SIRT1/PGC‐1α/PPARγ/NRF1/TFAM pathway through rationally designed mitochondria‐targeted biomimetic nanoparticles.